HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enrique Espinosa Selected Research

Indicators and Reagents (Reagents)

11/2022Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Enrique Espinosa Research Topics

Disease

38Neoplasms (Cancer)
09/2023 - 09/2004
25Breast Neoplasms (Breast Cancer)
01/2023 - 12/2005
24Melanoma (Melanoma, Malignant)
05/2024 - 03/2009
8Triple Negative Breast Neoplasms
12/2023 - 04/2013
8Neoplasm Metastasis (Metastasis)
01/2022 - 10/2006
7Carcinoma (Carcinomatosis)
01/2020 - 12/2002
6Infections
11/2016 - 02/2006
5HIV Infections (HIV Infection)
06/2021 - 02/2006
4Renal Cell Carcinoma (Grawitz Tumor)
07/2023 - 09/2012
3Uveal melanoma
11/2022 - 01/2021
3Diarrhea
01/2022 - 06/2018
3Immune Reconstitution Inflammatory Syndrome
06/2021 - 06/2011
2Kidney Neoplasms (Kidney Cancer)
01/2023 - 11/2010
2Weight Loss (Weight Reduction)
12/2021 - 03/2021
2Fatigue
06/2020 - 01/2015
2Disease Progression
01/2018 - 12/2010
2Ovarian Neoplasms (Ovarian Cancer)
03/2015 - 01/2008
2Pneumonia (Pneumonitis)
01/2014 - 11/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2012 - 11/2009
2Lung Neoplasms (Lung Cancer)
11/2009 - 04/2004
1Leiomyosarcoma
12/2023
1Sarcoma (Soft Tissue Sarcoma)
12/2023
1Synovial Sarcoma (Synovioma)
12/2023
1Retinoblastoma (Glioblastoma, Retinal)
01/2023
1Cardiotoxicity
02/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Febrile Neutropenia
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
12/2021

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
12/2023 - 05/2009
13ParaffinIBA
09/2023 - 01/2008
12Proteins (Proteins, Gene)FDA Link
09/2023 - 12/2005
9Formaldehyde (Formol)FDA Link
01/2022 - 01/2008
5Phenobarbital (Luminal)FDA Link
01/2023 - 01/2017
5VemurafenibIBA
12/2021 - 04/2014
5Bevacizumab (Avastin)FDA Link
04/2016 - 11/2010
5Paclitaxel (Taxol)FDA LinkGeneric
04/2016 - 01/2008
4Immune Checkpoint InhibitorsIBA
12/2023 - 11/2021
4ProteomeIBA
01/2023 - 12/2005
4Hormones (Hormone)IBA
01/2023 - 04/2013
4IpilimumabIBA
01/2021 - 12/2014
4Estrogen ReceptorsIBA
11/2017 - 06/2015
4CytokinesIBA
05/2014 - 12/2010
3taxaneIBA
12/2023 - 01/2014
3Dacarbazine (DIC)FDA LinkGeneric
12/2023 - 04/2014
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2023 - 06/2020
3RNA (Ribonucleic Acid)IBA
09/2023 - 05/2010
3Docetaxel (Taxotere)FDA Link
01/2022 - 04/2012
3Peptides (Polypeptides)IBA
11/2021 - 11/2009
3NivolumabIBA
01/2021 - 01/2019
3MicroRNAs (MicroRNA)IBA
01/2020 - 06/2015
3InterferonsIBA
06/2018 - 12/2010
2130-nm albumin-bound paclitaxelIBA
12/2023 - 11/2017
2dabrafenibIBA
10/2023 - 01/2015
2Tyrosine Kinase InhibitorsIBA
07/2023 - 01/2015
2AntibodiesIBA
01/2023 - 01/2021
2Fatty Acids (Saturated Fatty Acids)IBA
01/2023 - 10/2019
2tebentafuspIBA
11/2022 - 11/2021
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2022 - 11/2021
2Trastuzumab (Herceptin)FDA Link
02/2022 - 01/2014
2Phosphotransferases (Kinase)IBA
11/2021 - 01/2015
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 07/2013
2Androgen Receptors (Androgen Receptor)IBA
06/2019 - 01/2019
2Sunitinib (Sutent)FDA Link
06/2018 - 11/2010
2Vinorelbine (Navelbine)FDA LinkGeneric
01/2018 - 12/2002
2ErbB Receptors (EGF Receptor)IBA
11/2017 - 01/2017
2Taxoids (Taxanes)IBA
11/2017 - 07/2013
2Proto-Oncogene Proteins B-rafIBA
01/2017 - 04/2014
2Messenger RNA (mRNA)IBA
11/2016 - 11/2008
2Carboplatin (JM8)FDA LinkGeneric
03/2015 - 01/2008
2Immunomodulating AgentsIBA
01/2015 - 11/2011
2Fluorouracil (Carac)FDA LinkGeneric
07/2013 - 12/2002
2ChemokinesIBA
04/2013 - 11/2011
1ipatasertibIBA
12/2023
1atezolizumabIBA
12/2023
1pazopanibFDA Link
12/2023
1GemcitabineFDA Link
12/2023
1IfosfamideFDA LinkGeneric
12/2023
1trametinibIBA
10/2023
14- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
01/2023
1acylcarnitineIBA
01/2023
1palbociclibIBA
01/2023
1Retinoblastoma ProteinIBA
01/2023
1Indicators and Reagents (Reagents)IBA
11/2022
1Opioid Analgesics (Opioids)IBA
01/2022
1SuspensionsIBA
01/2022
1CreatinineIBA
12/2021
1Serum AlbuminIBA
12/2021
1Hemoglobins (Hemoglobin)IBA
12/2021
1cobimetinibIBA
12/2021
1Glycoproteins (Glycoprotein)IBA
11/2021

Therapy/Procedure

30Therapeutics
12/2023 - 09/2004
14Drug Therapy (Chemotherapy)
09/2023 - 03/2009
7Immunotherapy
05/2024 - 01/2015
5Neoadjuvant Therapy
01/2023 - 11/2017
3Adjuvant Chemotherapy
01/2017 - 04/2004
2Combination Drug Therapy (Combination Chemotherapy)
03/2021 - 04/2013
2Highly Active Antiretroviral Therapy (HAART)
02/2006 - 04/2005
1Treatment Delay
01/2022
1Activities of Daily Living (ADL)
12/2021
1Art Therapy
06/2021